North Star Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.08M Buy
181,035
+19,625
+12% +$522K 0.31% 71
2025
Q4
$4.02M Sell
161,410
-11,439
-7% -$288K 0.25% 86
2025
Q3
$4.4M Buy
172,849
+1,134
+0.7% +$28K 0.28% 79
2025
Q2
$4.16M Sell
171,715
-5,119
-3% -$119K 0.29% 81
2025
Q1
$4.48M Sell
176,834
-3,292
-2% -$86.1K 0.33% 64
2024
Q4
$4.78M Sell
180,126
-108,881
-38% -$2.95M 0.33% 71
2024
Q3
$8.36M Sell
289,007
-3,118
-1% -$91K 0.58% 35
2024
Q2
$8.17M Buy
292,125
+41,508
+17% +$1.14M 0.6% 36
2024
Q1
$6.95M Sell
250,617
-61,326
-20% -$1.7M 0.5% 46
2023
Q4
$8.98M Sell
311,943
-8,771
-3% -$265K 0.69% 27
2023
Q3
$10.6M Buy
320,714
+23,296
+8% +$824K 0.9% 19
2023
Q2
$10.9M Sell
297,418
-274
-0.1% -$10.7K 0.88% 20
2023
Q1
$12.1M Buy
297,692
+30,474
+11% +$1.32M 1% 17
2022
Q4
$13.7M Sell
267,218
-11,776
-4% -$565K 1.22% 14
2022
Q3
$12.2M Buy
278,994
+4,407
+2% +$214K 1.2% 14
2022
Q2
$14.4M Sell
274,587
-274
-0.1% -$14K 1.31% 13
2022
Q1
$14.2M Buy
274,861
+2,157
+0.8% +$112K 1.11% 16
2021
Q4
$16.1M Buy
272,704
+1,776
+0.7% +$88K 1.13% 14
2021
Q3
$11.7M Sell
270,928
-819
-0.3% -$36.3K 0.95% 20
2021
Q2
$10.6M Buy
271,747
+14,293
+6% +$556K 0.84% 25
2021
Q1
$9.33M Buy
257,454
+34,668
+16% +$1.23M 0.88% 24
2020
Q4
$8.2M Buy
222,786
+8,710
+4% +$319K 0.85% 25
2020
Q3
$7.45M Buy
214,076
+36,575
+21% +$1.28M 0.88% 24
2020
Q2
$5.51M Buy
177,501
+12,342
+7% +$419K 0.72% 31
2020
Q1
$5.11M Sell
165,159
-32,913
-17% -$1.12M 0.76% 29
2019
Q4
$7.36M Sell
198,072
-836
-0.4% -$29.8K 0.77% 25
2019
Q3
$6.78M Buy
198,908
+26,626
+15% +$968K 0.75% 29
2019
Q2
$7.08M Sell
172,282
-2,073
-1% -$82.3K 0.82% 22
2019
Q1
$7.03M Sell
174,355
-2,032
-1% -$81.4K 0.82% 23
2018
Q4
$7.3M Sell
176,387
-1,561
-0.9% -$64.8K 0.95% 19
2018
Q3
$7.44M Buy
177,948
+2,008
+1% +$77.3K 0.83% 22
2018
Q2
$6.06M Buy
175,940
+388
+0.2% +$13.3K 0.7% 29
2018
Q1
$5.91M Buy
175,552
+13,064
+8% +$449K 0.71% 30
2017
Q4
$5.58M Buy
162,488
+8,384
+5% +$286K 0.68% 32
2017
Q3
$5.22M Sell
154,104
-6,373
-4% -$205K 0.66% 35
2017
Q2
$5.11M Buy
160,477
+22,110
+16% +$697K 0.68% 26
2017
Q1
$4.49M Buy
138,367
+5,088
+4% +$160K 0.62% 34
2016
Q4
$4.11M Sell
133,279
-28,650
-18% -$875K 0.62% 32
2016
Q3
$5.2M Buy
161,929
+4,308
+3% +$144K 0.93% 17
2016
Q2
$5.27M Sell
157,621
-10,132
-6% -$323K 0.97% 16
2016
Q1
$4.72M Buy
167,753
+3,568
+2% +$102K 0.9% 18
2015
Q4
$5.03M Buy
164,185
+3,477
+2% +$109K 0.98% 14
2015
Q3
$4.79M Buy
160,708
+324
+0.2% +$10.4K 0.98% 14
2015
Q2
$5.1M Buy
160,384
+570
+0.4% +$18.6K 0.94% 16
2015
Q1
$5.28M Sell
159,814
-7,966
-5% -$253K 0.99% 14
2014
Q4
$4.96M Buy
167,780
+12,662
+8% +$363K 0.95% 17
2014
Q3
$4.35M Buy
155,118
+1,190
+0.8% +$33.4K 0.87% 22
2014
Q2
$4.33M Buy
153,928
+7,361
+5% +$210K 0.87% 19
2014
Q1
$4.47M Buy
146,567
+15,708
+12% +$468K 0.93% 19
2013
Q4
$3.8M Buy
130,859
+37,062
+40% +$1.08M 0.83% 28
2013
Q3
$2.56M Buy
93,797
+1,625
+2% +$44.2K 0.68% 41
2013
Q2
$2.45M Buy
+92,172
New +$2.55M 0.63% 40

Other funds holding PFE

North Star Investment Management's PFE Position: Q1 2026 in Review

North Star Investment Management increased its Pfizer (PFE) stake by 12% in Q1 2026, buying an estimated $522K and bringing the position to 181,035 shares worth $5.08M. The position accounts for 0.31% of the portfolio, ranked #71.

North Star Investment Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $16.1M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • North Star Investment Management held 181,035 shares of Pfizer worth $5.08M as of Q1 2026.
  • North Star Investment Management bought 19,625 Pfizer shares in Q1 2026, an estimated $522K.
  • Pfizer made up 0.31% of North Star Investment Management's portfolio in Q1 2026, its #71 holding.
  • North Star Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • North Star Investment Management's Pfizer position peaked at $16.1M in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.